Information about the Pfizer-BioNTech COVID-19 vaccine
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
i

Superseded

This Document Has Been Replaced By:

i

Retired

This Document Has Been Retired

i

Up-to-date Information

This is the latest update:

Information about the Pfizer-BioNTech COVID-19 vaccine
Filetype[PDF-141.91 KB]


Details:
No Related Documents.

You May Also Like:

  1. Filetype[PDF - 1.59 MB]
    Personal Author:
    Cohn, Amanda; Mbaeyi, Sarah; Oliver, Sara;
    Corporate Authors:
    Centers for Disease Control and Prevention (U.S.). Office of Public Health Preparedness and Response. Clinician Outreach and Communication Activity.. CDC COVID-19 Response.. National Center for Immunization and Respiratory Diseases (U.S.). United States. Advisory Committee on Immunization Practices. COVID-19 Vaccines Work Group..
    Published Date:
    December 18, 2020
    Series:
    Clinician Outreach and Communication Activity (COCA) Webinar
    Description:
    Date: Friday, December 18, 2020Time: 2:00 PM – 3:00 PM ETThis COCA Call will give clinicians an overview of the Pfizer-BioNTech and Moderna COVID-19 vaccines. Clinicians will learn about vaccine characteristics and administration, vaccinating speci...
    File Type:
    Filetype[PDF - 1.59 MB]
  2. Filetype[PDF - 124.10 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Dec. 20, 2020
    Description:
    Updated Dec. 20, 2020Name: BNT162b2Manufacturer: Pfizer, Inc., and BioNTechType of vaccine: mRNAmRNA vaccines are a new type of vaccine to protect against infectious diseases. These vaccines teach our cells how to make a protein—or even just a piec...
    File Type:
    Filetype[PDF - 124.10 KB]
  3. Filetype[PDF - 138.33 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Published Date:
    December 22, 2020
    File Type:
    Filetype[PDF - 138.33 KB]
  4. Filetype[PDF - 113.10 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
    Published Date:
    Dec. 23, 2020
    Description:
    Updated Dec. 23, 2020Name: mRNA-1273Manufacturer: ModernaTX, Inc.Type of vaccine: mRNAmRNA vaccines are a new type of vaccine to protect against infectious diseases. These vaccines teach our cells how to make a protein—or even just a piece of a pro...
    File Type:
    Filetype[PDF - 113.10 KB]
  5. Filetype[PDF - 148.94 KB]
    Corporate Authors:
    National Center for Immunization and Respiratory Diseases (U.S.)
    Published Date:
    December 22, 2020
    File Type:
    Filetype[PDF - 148.94 KB]